CyTuVax reports results from phase II trial of HBAI-20 vaccine in hepatitis B nonresponders June 19, 2019
Antitumor activity seen for acalabrutinib + pembrolizumab combination in relapsed/refractory DLBCL June 19, 2019
Miransertib studied in patients with PIK3CA-related overgrowth spectrum and Proteus syndrome June 19, 2019
Nanjing TransThera Biosciences identifies semicarbazide-sensitive amine oxidase inhibitors June 19, 2019
RSS